Epidemiological summary of multiple myeloma in the Gomel region and the Republic of Belarus over the past 15 years
https://doi.org/10.58708/2074-2088.2025-3(35)-19-26
Abstract
Multiple myeloma is a plasma cell neoplasm and is often diagnosed in elderly patients. The increase in the average life expectancy of the population in the Republic of Belarus makes it relevant to study the prevalence, incidence, and mortality from chronic oncological diseases, including multiple myeloma. The article presents the results of a statistical analysis of epidemiological indicators of multiple myeloma based on data from the Belarusian Cancer Registry from 2010 to 2024, as well as data from follow-up monitoring of patients with multiple myeloma residing in the Gomel region from 2020 to 2024.
About the Authors
M. V. Linkou
ГУ «РНПЦ радиационной медицины и экологии человека»
Belarus
Belarus
I. V. Veyalkin
ГУ «РНПЦ радиационной медицины и экологии человека»
Belarus
Belarus
Zh. M. Kozich
ГУ «РНПЦ радиационной медицины и экологии человека»
Belarus
Belarus
K. S. Yauseichyk
ГУ «РНПЦ радиационной медицины и экологии человека»
Belarus
Belarus
N. N. Usova
УО «Гомельский государственный медицинский университет»
Belarus
Belarus
References
1. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma / S.V. Rajkumar, M.A. Dimopoulos, A. Palumbo [et al.] // Lancet Oncol. – 2014. – Vol. 15, № 12. – P. 538–548.
2. Множественная миелома. Клинические рекомендации / Л.П. Менделеева, О.М. Вотякова, И.Г. Рехтина [и др.] // Современная онкология. – 2020. – Т. 22, № 4. – С. 6–28.
3. Global cancer statistics 2020: GLOBOCAN estimates of Incidence and mortality worldwide for 36 cancers in 185 countries / H. Sung, J. Ferlay, R.L. Siegel [et al.] // CA. Cancer J. Clin. – 2021. – Vol. 71, № 3. – P. 209–249.
4. Epidemiology, staging, and management of multiple myeloma / S.A. Padala, A. Barsouk, A. Barsouk [et al.] // Med. Sci. – 2021. – Vol. 9, № 1. – P. 1–14.
5. Racial disparities in incidence and outcome in multiple myeloma: a population-based study / A.J. Waxman, P.J. Mink, S.S. Devesa [et al.] // Blood. – 2010. – Vol. 116, № 25. – P. 5501–5506.
6. Global burden of multiple myeloma: a systematic analysis for the global burden of disease study 2016 / A.J. Cowan, C. Allen, A. Barac [et al.] // JAMA Oncol. – 2018. – Vol. 4, № 9. – P. 1–17.
7. SEER Cancer Statistics Review, 1975-2016, National Cancer Institute. Bethesda, MD: [National Cancer Institute. Surveillance, Epidemiology, and End Results Program] / N. Howlader, A.M. Noone, M. Krapcho [et al.]. – URL: https://seer.cancer.gov/csr/1975_2016/index.html (date of access: 06.04.2025).
8. Эпидемиологическая характеристика множественной миеломы в Республике Беларусь за 2010–2019 годы / М.В. Линков, И.В. Веялкин, Д.К. Новик, Н.Н. Усова // Медико-биологические проблемы жизнедеятельности. – 2021. – № 1 (25). – С. 130–134.
9. Моисеев, П.И. / Эпидемиология злокачественных новообразований: принципы и методы / П.И. Моисеев, И.В. Веялкин, Ю.Е. Демидчик // Руководство по онкологии: учебник / О.Г. Суконко [и др.]; под ред. О.Г. Суконко. – Мн., 2015. – С. 51-82.
10. Estimating average annual percent change for disease rates without assuming constant change / M.P. Fay [et al.] // Biometrics. – 2006. – Vol. 62, № 3. – P. 847–854.
11.
Review
For citations:
Linkou M.V., Veyalkin I.V., Kozich Zh.M., Yauseichyk K.S., Usova N.N. Epidemiological summary of multiple myeloma in the Gomel region and the Republic of Belarus over the past 15 years. Medical and Biological Problems of Life Activity. 2025;(3):19-26. (In Russ.) https://doi.org/10.58708/2074-2088.2025-3(35)-19-26
Views:
4
Email this article 